Provident Investment Management’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,850	Closed	-$54K	–	58
2022 Q1	$54K	Buy	+10,850	New	+$54K	0.01%	62